Predictive value of abbreviated olfactory tests in prodromal Parkinson disease.


Journal

NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390

Informations de publication

Date de publication:
29 Jun 2023
Historique:
received: 11 07 2022
accepted: 22 05 2023
medline: 30 6 2023
pubmed: 30 6 2023
entrez: 29 6 2023
Statut: epublish

Résumé

There is disagreement in the literature whether olfaction may show specific impairments in Parkinson Disease (PD) and if olfactory tests comprised of selected odors could be more specific for diagnosis. We sought to validate previously proposed subsets of the University of Pennsylvania Smell Identification Test (UPSIT) odors for predicting conversion to PD in an independent, prodromal cohort. Conversion to PD was assessed in 229 participants in the Parkinson At Risk Study who completed baseline olfactory testing with the UPSIT and up to 12 years of clinical and imaging evaluations. No commercially available or proposed subset performed better than the full 40-item UPSIT. The proposed "PD-specific" subsets also did not perform better than expected by chance. We did not find evidence for selective olfactory impairment in Parkinson disease. Shorter odor identification tests, including commercially available 10-12 item tests, may have utility for ease of use and cost, but not for superior predictive value.

Identifiants

pubmed: 37386033
doi: 10.1038/s41531-023-00530-z
pii: 10.1038/s41531-023-00530-z
pmc: PMC10310835
doi:

Types de publication

Journal Article

Langues

eng

Pagination

103

Subventions

Organisme : U.S. Department of Defense (United States Department of Defense)
ID : W81XWH-06-067
Organisme : U.S. Department of Defense (United States Department of Defense)
ID : W81XWH-06-067
Organisme : U.S. Department of Defense (United States Department of Defense)
ID : W81XWH-06-067
Organisme : U.S. Department of Defense (United States Department of Defense)
ID : W81XWH-06-067
Organisme : U.S. Department of Defense (United States Department of Defense)
ID : W81XWH-06-067

Investigateurs

John Seibyl (J)
Matthew Stern (M)
David Russell (D)
Kapil Sethi (K)
Samuel Frank (S)
Tanya Simuni (T)
Robert Hauser (R)
Bernard Ravina (B)
Irene Richards (I)
Grace Liang (G)
Charles Adler (C)
Rachel Saunders-Pullman (R)
Marian L Evatt (ML)
Eugene Lai (E)
Indu Subramanian (I)
Penelope Hogarth (P)
Kathryn Chung (K)

Informations de copyright

© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Ann Clin Transl Neurol. 2017 Sep 08;4(10):714-721
pubmed: 29046880
Mov Disord. 2020 Sep;35(9):1550-1557
pubmed: 32657461
J Neurol Neurosurg Psychiatry. 1997 May;62(5):436-46
pubmed: 9153598
Mov Disord. 2015 Oct;30(12):1600-11
pubmed: 26474317
NPJ Parkinsons Dis. 2018 Jan 15;4:2
pubmed: 29354684
Biomark Med. 2010 Oct;4(5):661-70
pubmed: 20945979
Mov Disord. 2008 Oct 30;23(14):1984-90
pubmed: 18759360
Neurol Sci. 2014 Mar;35(3):379-83
pubmed: 23975523
Arch Neurol. 2003 Apr;60(4):545-9
pubmed: 12707068
Arch Clin Neuropsychol. 2019 Jun 1;34(4):435-444
pubmed: 30007334
Mov Disord. 2019 Oct;34(10):1464-1470
pubmed: 31412427
Mov Disord. 2012 Mar;27(3):406-12
pubmed: 22237833
J Parkinsons Dis. 2019;9(s2):S281-S295
pubmed: 31498132
Mov Disord. 2007 Apr 30;22(6):839-42
pubmed: 17357143
BMC Bioinformatics. 2008 Jun 05;9:265
pubmed: 18534022
Mov Disord Clin Pract. 2015 Jul 17;3(1):43-47
pubmed: 30363525
J Clin Neurosci. 2019 Feb;60:68-72
pubmed: 30340975
Parkinsonism Relat Disord. 2009 Nov;15(9):640-3
pubmed: 19329351
Neurosci Bull. 2017 Oct;33(5):515-525
pubmed: 28831680
Ann Neurol. 2004 Aug;56(2):173-81
pubmed: 15293269
J Neurol. 2007 Jan;254(1):84-90
pubmed: 17508142
Clin Neurol Neurosurg. 2014 Aug;123:9-14
pubmed: 25012004
Mov Disord. 2008 Dec 15;23(16):2328-34
pubmed: 18785265
Int J Neurosci. 2010 Jan;120(1):36-9
pubmed: 20128670
Nat Neurosci. 2014 Jan;17(1):114-20
pubmed: 24316890
Neurology. 1988 Aug;38(8):1237-44
pubmed: 3399075
Parkinsonism Relat Disord. 2009 Aug;15(7):490-4
pubmed: 19138875
PLoS One. 2016 Nov 17;11(11):e0165112
pubmed: 27855167
J Neural Transm (Vienna). 2016 Apr;123(4):421-4
pubmed: 26911386
J Assoc Physicians India. 2016 Apr;64(4):32-36
pubmed: 27734639
Mov Disord. 2011 Jan;26(1):173-6
pubmed: 20842690
Mov Disord Clin Pract. 2020 Mar 21;7(4):394-398
pubmed: 32373655
Neurology. 1998 Dec;51(6):1672-7
pubmed: 9855521
Ann Neurol. 2008 Feb;63(2):167-73
pubmed: 18067173
J Clin Neurosci. 2020 Jun;76:31-35
pubmed: 32331947
Laryngoscope. 1996 Mar;106(3 Pt 1):353-6
pubmed: 8614203
QJM. 2010 Dec;103(12):941-52
pubmed: 20736182
J Parkinsons Dis. 2014;4(2):175-80
pubmed: 24796234
Handb Clin Neurol. 2019;164:229-246
pubmed: 31604550
J Neurol. 2019 Aug;266(8):1897-1906
pubmed: 31053960

Auteurs

Pavan A Vaswani (PA)

Parkinson's Disease Research, Education and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA. pavan.vaswani@pennmedicine.upenn.edu.
Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. pavan.vaswani@pennmedicine.upenn.edu.

James F Morley (JF)

Parkinson's Disease Research, Education and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Danna Jennings (D)

The Institute for Neurodegenerative Disorders, New Haven, CT, USA.

Andrew Siderowf (A)

Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Kenneth Marek (K)

The Institute for Neurodegenerative Disorders, New Haven, CT, USA.

Classifications MeSH